Tech Company Financing Transactions
Quark Pharmaceuticals Funding Round
Quark Pharmaceuticals, based in Fremont, secured $10 million in investment from SBI Holding.
Transaction Overview
Company Name
Announced On
6/10/2010
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Undisclosed
Investors
SBI Holding (Robert Takeuchi)
Proceeds Purpose
Quark Pharmaceuticals will use the funds to advance its RNAi drug pipeline, which has the largest number of clinical-stage siRNA therapeutic programs in the industry. The Company's pipeline candidates are currently being evaluated in five different clinical trials.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
6501 Dumbarton Cir.
Fremont, CA 94555
USA
Fremont, CA 94555
USA
Phone
Website
Email Address
Overview
Quark Pharmaceuticals, Inc. is a development-stage pharmaceutical company engaged in discovering and developing novel therapeutic RNAi drug candidates. Quark has a fully integrated drug development platform that spans therapeutic target identification to drug development.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Daniel Zurr
Chief Financial Officer
Tomer Natan
Chief Medical Officer
Elizabeth Squiers
Chief Scientific Officer
Elena Feinstein
VP - Bus. Development
Juliana Friedmann
Browse more venture capital transactions:
Prev: 6/10/2010: Crowdcast venture capital transaction
Next: 6/10/2010: SoonR venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs